Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Enrolling by invitation 1Completed 1

Sponsor Class

INDUSTRY 3OTHER 2UNKNOWN 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 217Head & Neck 9Thoracic 8Tumor-Agnostic 4Other solid neoplasm 2Breast 2NET 1Genitourinary 1Endocrine 1

Conditions

Solid Tumor 1Advanced Solid Tumors 1

Interventions

Cisplatin 60Carboplatin 55Cyclophosphamide 47Pemetrexed 45Irinotecan 33pembrolizumab 32Paclitaxel 29Etoposide 29Gemcitabine 28Nivolumab 24Bevacizumab 24Interviews as Topic 23Vincristine 22Capecitabine 22Topotecan 20Filgrastim 20Early Intervention, Educational 20fludarabine 19Oxaliplatin 19Docetaxel 19Specimen Handling 18Drug Therapy 18Temozolomide 17Sorafenib 17Leucovorin 17Everolimus 17Educational Status 17Radiotherapy 16Methods 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × S 1 (combination) × Other solid neoplasm × Clear all
NCT04260269 2024-12-12

CardioSwitch

Helsinki University Central Hospital

Enrolling by invitation
200 enrolled
Other solid neoplasm

Solid Tumor

NCT01128998 2015-10-19

Sorafenib Plus S-1 in Advanced Solid Tumors

National Health Research Institutes, Taiwan

Phase 1 Completed
30 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡